Renaissance Technologies’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $867K | Sell |
32,700
-295,000
| -90% | -$7.82M | ﹤0.01% | 2581 |
|
2025
Q1 | $7.91M | Buy |
+327,700
| New | +$7.91M | 0.01% | 1137 |
|
2024
Q4 | – | Sell |
-184,100
| Closed | -$11.7M | – | 3939 |
|
2024
Q3 | $11.7M | Buy |
184,100
+24,700
| +15% | +$1.56M | 0.02% | 964 |
|
2024
Q2 | $8.45M | Buy |
+159,400
| New | +$8.45M | 0.01% | 1018 |
|
2023
Q3 | – | Sell |
-57,000
| Closed | -$924K | – | 4144 |
|
2023
Q2 | $924K | Sell |
57,000
-704,200
| -93% | -$11.4M | ﹤0.01% | 2513 |
|
2023
Q1 | $12.7M | Sell |
761,200
-189,400
| -20% | -$3.15M | 0.02% | 964 |
|
2022
Q4 | $8.94M | Sell |
950,600
-95,800
| -9% | -$901K | 0.01% | 1152 |
|
2022
Q3 | $2.85M | Buy |
1,046,400
+180,200
| +21% | +$490K | ﹤0.01% | 1793 |
|
2022
Q2 | $2.5M | Sell |
866,200
-101,149
| -10% | -$292K | ﹤0.01% | 2026 |
|
2022
Q1 | $2.9M | Buy |
967,349
+724,476
| +298% | +$2.17M | ﹤0.01% | 1948 |
|
2021
Q4 | $1.12M | Buy |
+242,873
| New | +$1.12M | ﹤0.01% | 2562 |
|
2021
Q1 | – | Sell |
-179,000
| Closed | -$1.01M | – | 3738 |
|
2020
Q4 | $1.01M | Buy |
179,000
+141,900
| +382% | +$799K | ﹤0.01% | 2490 |
|
2020
Q3 | $216K | Buy |
+37,100
| New | +$216K | ﹤0.01% | 3082 |
|
2018
Q2 | – | Sell |
-832,500
| Closed | -$3.64M | – | 3548 |
|
2018
Q1 | $3.64M | Sell |
832,500
-70,800
| -8% | -$309K | ﹤0.01% | 2020 |
|
2017
Q4 | $3.67M | Buy |
903,300
+500,700
| +124% | +$2.03M | ﹤0.01% | 1994 |
|
2017
Q3 | $769K | Buy |
402,600
+103,600
| +35% | +$198K | ﹤0.01% | 2667 |
|
2017
Q2 | $323K | Buy |
299,000
+33,200
| +12% | +$35.9K | ﹤0.01% | 2882 |
|
2017
Q1 | $388K | Buy |
265,800
+102,600
| +63% | +$150K | ﹤0.01% | 2845 |
|
2016
Q4 | $194K | Buy |
163,200
+141,900
| +666% | +$169K | ﹤0.01% | 3012 |
|
2016
Q3 | $30K | Buy |
+21,300
| New | +$30K | ﹤0.01% | 3278 |
|